Customized Chemotherapy Did Not Improve Survival in Early NSCLC ...Middle East

Tailoring adjuvant chemotherapy based on the expression of two molecular markers did not confer a survival advantage in patients with completely resected stage 2-3 NSCLC in a phase 3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Customized Chemotherapy Did Not Improve Survival in Early NSCLC )

Also on site :

• BMW secretly followed, filmed and then sacked worker over injury claim
• Hamas agrees to release 10 hostages as Trump says there’s a ‘very good chance’ for ceasefire deal this week
• I Use This Solar-Powered Security Camera to Keep My Home Safe, and It's $24 Off for Prime Day